Case of severe acneiform eruptions associated with the BRAF inhibitor vemurafenib

被引：5
|
作者：
Ansai, Osamu [1 ]
Fujikawa, Hiroki [1 ]
Shimomura, Yutaka [1 ]
Abe, Riichiro [1 ]
机构：
[1] Niigata Univ, Grad Sch Sci & Technol, Div Dermatol, Chuo Ku, 1-757 Asahimachi dori, Niigata 9518510, Japan
来源：
JOURNAL OF DERMATOLOGY | 2017年 / 44卷 / 03期
关键词：
METASTATIC MELANOMA;
D O I：
10.1111/1346-8138.13534
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E15 / E16
页数：2
相关论文
共 50 条
  • [21] Abrupt development of Dupuytren's contractures with the BRAF inhibitor vemurafenib
    Couderc, Marion
    Soubrier, Martin
    JOINT BONE SPINE, 2014, 81 (04) : 373 - 374
  • [22] Severe acneiform eruption to EGFR inhibitor treated with isotretinoin
    McKesey, Jacqueline
    Jamison, Megan
    DeKlotz, Cynthia
    Blankenship, D. Winslow
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB234 - AB234
  • [23] BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions
    Wallach, Jonathan B.
    Rietschel, Petra
    Kalnicki, Shalom
    Fox, Jana L.
    PRACTICAL RADIATION ONCOLOGY, 2014, 4 (05) : E213 - E216
  • [24] Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients
    Boussemart, L.
    Routier, E.
    Mateus, C.
    Opletalova, K.
    Sebille, G.
    Kamsu-Kom, N.
    Thomas, M.
    Vagner, S.
    Favre, M.
    Tomasic, G.
    Wechsler, J.
    Lacroix, L.
    Robert, C.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1691 - 1697
  • [25] Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
    Yang, Hong
    Higgins, Brian
    Kolinsky, Kenneth
    Packman, Kathryn
    Bradley, William D.
    Lee, Richard J.
    Schostack, Kathleen
    Simcox, Mary Ellen
    Kopetz, Scott
    Heimbrook, David
    Lestini, Brian
    Bollag, Gideon
    Su, Fei
    CANCER RESEARCH, 2012, 72 (03) : 779 - 789
  • [26] A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
    Maleka, A.
    Astrom, G.
    Bystrom, P.
    Ullenhag, G. J.
    BMC CANCER, 2016, 16
  • [27] A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
    A. Maleka
    G. Åström
    P. Byström
    G. J. Ullenhag
    BMC Cancer, 16
  • [28] Desvenlafaxine-Triggered Acneiform Eruptions on the Hand: A Compelling Case Report
    Yadav, Anupam S.
    Singh, Sonali
    Randhawa, Jaismeen
    Akuma, Chinaza M.
    Akuma, Ogbonnaya
    Chaudhry, Hassan A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [29] CHARACTERIZATION OF RESISTANCE MECHANISMS TO THE BRAF INHIBITOR VEMURAFENIB (PLX4032)
    Azimi, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 23
  • [30] Vemurafenib (BRAF Inhibitor) Therapy for Orbital Erdheim-Chester Disease
    Gupta, Adit
    Yeganeh, Amir
    Rootman, Daniel
    Goldberg, Robert
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (06): : E138 - E139
12345